CN101035556A - 有机化合物的用途 - Google Patents

有机化合物的用途 Download PDF

Info

Publication number
CN101035556A
CN101035556A CNA2005800339490A CN200580033949A CN101035556A CN 101035556 A CN101035556 A CN 101035556A CN A2005800339490 A CNA2005800339490 A CN A2005800339490A CN 200580033949 A CN200580033949 A CN 200580033949A CN 101035556 A CN101035556 A CN 101035556A
Authority
CN
China
Prior art keywords
calcitonin
salmon calcitonin
bone
osteoporosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800339490A
Other languages
English (en)
Chinese (zh)
Inventor
M·阿兹里亚
C·克里斯蒂安森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Nordic Bioscience AS
Original Assignee
Novartis AG
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33443790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101035556(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG, Nordic Bioscience AS filed Critical Novartis AG
Publication of CN101035556A publication Critical patent/CN101035556A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2005800339490A 2004-10-12 2005-10-10 有机化合物的用途 Pending CN101035556A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0422644.5A GB0422644D0 (en) 2004-10-12 2004-10-12 Organic compounds
GB0422644.5 2004-10-12

Publications (1)

Publication Number Publication Date
CN101035556A true CN101035556A (zh) 2007-09-12

Family

ID=33443790

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800339490A Pending CN101035556A (zh) 2004-10-12 2005-10-10 有机化合物的用途

Country Status (13)

Country Link
US (1) US20090048157A1 (https=)
EP (1) EP1802328A1 (https=)
JP (1) JP2008515947A (https=)
KR (1) KR20070061864A (https=)
CN (1) CN101035556A (https=)
AU (1) AU2005293802A1 (https=)
BR (1) BRPI0516872A (https=)
CA (1) CA2580766A1 (https=)
GB (1) GB0422644D0 (https=)
MX (1) MX2007004259A (https=)
RU (1) RU2007117492A (https=)
TW (1) TW200628168A (https=)
WO (1) WO2006040114A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2469709C2 (ru) * 2005-11-17 2012-12-20 Новартис Аг Фармацевтическая композиция
CN102292346B (zh) 2009-01-22 2015-12-02 关键生物科学有限公司 肥胖的治疗
EP2773365B1 (en) * 2011-11-02 2016-07-20 KeyBioscience AG Peptide analogs for treating diseases and disorders
BR112014010701A2 (pt) * 2011-11-02 2020-06-23 Keybioscience Ag Uso de um peptídeo
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
CN107345965A (zh) * 2016-05-04 2017-11-14 广州优迪生物科技有限公司 一种同时检测N-MID和β-CTX的双标记时间分辨荧光免疫分析方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
IT1282374B1 (it) * 1996-01-31 1998-03-20 Therapicon Srl Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita'
EP1175390B1 (en) * 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
US20040110170A1 (en) * 2002-05-18 2004-06-10 The Regents Of The University Of California Cloning and characterization of calcitonin gene related peptide receptors
TW200411053A (en) * 2002-12-30 2004-07-01 Ind Tech Res Inst Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith

Also Published As

Publication number Publication date
RU2007117492A (ru) 2008-11-20
WO2006040114A1 (en) 2006-04-20
AU2005293802A1 (en) 2006-04-20
BRPI0516872A (pt) 2008-09-23
KR20070061864A (ko) 2007-06-14
JP2008515947A (ja) 2008-05-15
US20090048157A1 (en) 2009-02-19
MX2007004259A (es) 2007-05-11
EP1802328A1 (en) 2007-07-04
GB0422644D0 (en) 2004-11-10
TW200628168A (en) 2006-08-16
CA2580766A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
TWI222360B (en) Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
JP4220235B2 (ja) 短期及び長期の薬剤薬量決定のための方法
JP5042312B2 (ja) Ｈｇｈを含む経口送達用医薬組成物
ES2630012T3 (es) Formulaciones virales liofilizadas
JP2003500360A (ja) ボロプロリン化合物類を含む抗癌剤
WO2010121570A1 (zh) 甲基斑蝥胺化合物及使用其的治疗方法、其制备方法
KR20090034404A (ko) 외투층 세포 림프종의 치료에 있어서 3-(4-아미노-1-옥소-1,3-디히드로-이소인돌-2-일)-피페리딘-2,6-디온의 용도
AU2014350328A1 (en) Calcitonin mimetics for treating diseases and disorders
JP2016511747A (ja) ナノ粒子表面結合に基づく薬物の組織への送達
JP2015518835A (ja) 癌幹細胞を標的とした癌ワクチン
CN101068561A (zh) 用于加强抗血管生成疗法的方法和组合物
CN101035556A (zh) 有机化合物的用途
CN1512892A (zh) 口服施用甲状旁腺激素和降钙素
EP0285441B1 (en) Synergistic immunostimulating composition and method
JP2009539916A (ja) ステージＩＶの悪性黒色腫の処置のための医薬品の製造のためのチモシンα１の使用
CN104822369A (zh) 包含穗霉素衍生物的组合物及其使用方法
US8232318B2 (en) Approaches to treat cancer using HB-EGF inhibitors
JP2012530740A (ja) がん治療の為のコルチコトロピン放出因子の使用方法
JP4066460B2 (ja) 骨疾患治療薬
CN1157566A (zh) 用于骨质疏松症的膦酸盐类和甲状旁腺激素
JP2003095974A (ja) 骨形成を安全に促進させる医薬複合剤
KR20060107792A (ko) 중증 골 소실 질환의 치료를 위한 카텝신 ｋ 억제제의 용도
KR101394594B1 (ko) 골 재흡수 및 골 형성 간의 불균형을 보정하는 방법 및 이를 위한 키트 및 조성물
JPH09510737A (ja) 化学療法剤を増強するためのｉｌ−４の使用
US20240216465A1 (en) Method for treating refractory brain tumor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070912